Ubisoft, Smile Group and Com2uS all contributed to a round which pushed the blockchain game developer’s valuation past $2.2bn.
Month: October 2021
Clounix closes two rounds
The networking technology developer raised $62.6m between an Inspur Group-backed angel round and a pre-series A.
D&D Pharmatech decides on $51m series C
Sumitomo Mitsui’s DS Asset Management subsidiary backed the neurological and metabolic disorder drug developer in a round that will support clinical trials.
ShouTi shoots to $100m series B round
Eli Lilly, WuXi AppTec and Schrodinger were among the investors in the cardiovascular, pulmonary and metabolic disorder drug developer’s latest round.
CargoX hauls in $200m in funding
SoftBank and Tencent provided a combined $150m to co-lead a series F round valuing the trucking services marketplace at $1bn.
Instacart pulls off $350m Caper AI purchase
Red Apple Group is exiting the smart trolley provider, which is being taken over by Instacart in a cash-and-stock deal.
Illovsky rolls to CapitalG
Lauren Illovsky has taken up a talent partner role at Alphabet’s CapitalG subsidiary following nearly two years in the same position at sister fund Gradient Ventures.
Data analytics unlocks new frontier for healthcare providers
Digital health drives healthcare investments to record heights
Daily Deal Round Up: October 21, 2021
Battery swapping service Sun Mobility closed $50m in funding from Vitol while Sinopharm-backed drug developer Sinotau raised the same amount in a series D-plus round.
Dreame hoovers up $563m in funding
Xiaomi returned for the smart home appliance producer’s series C round, which also featured Country Garden Ventures.
Cybereason swells series F to $325m
Google Cloud bolstering the cybersecurity software provider’s latest round with a $50m investment that took its total funding to $713m.
Flock Freight locks up $215m series D
SoftBank, Alphabet and GLP helped the digital freight management service reach unicorn status as it looks further develop its technology and scale operations.
Saama cedes majority stake for $430m
Amgen, Merck & Co, Pfizer, Intermountain and McKesson were among the investors to jointly acquire a majority of the clinical trials software producer’s shares.
AutoGrid grips $85m in series D-2 funding
Schneider Electric has returned to reinvest in the energy management platform operator’s latest round, which also featured GS Group, National Grid, Shell, SolarEdge and TotalEnergies.